Spotlight
Video

ENCORE 601: ENT in combination with PEMBRO in Advanced Melanoma Patients

Loading........
Description: Briggs Morrison MD, CEO of Syndax Pharmaceuticals, Inc. gives an overview of his presentation, Abstract #9529 ENCORE 601: A phase II study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with melanoma, which was discussed at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : AnnualMeeting2017
Posted on : 06/02/17
Added : 6 months ago



Recommended

Nothing found.

More From AnnualMeeting2017

Nothing found.